Elevat3 Capital

Check Size
€5M – €20M

Investment Focus

Investment Stages

Geographic Focus

Europe

Inferred Thesis

Auto-generated from public data. Not the firm's stated position.

Elevat3 Capital appears to focus on Series A and Series B investments across agritech, biotech, and cleantech sectors, with check sizes between €5.0M and €20.0M, though recent portfolio companies suggest broader exposure to digital services and subscription-based business models beyond disclosed sector categories.

Generated 9 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].

How to Pitch Elevat3 Capital

No Stated Policy
Elevat3 Capital hasn't published an outreach policy. A short, specific cold email is the safest default.

Who To Contact

Christian Angermayer
Co-Founder & General Partner
Life Sciences
FinTech
Crypto
Future Tech
Dr. Marlon Braumann
Co-Founder & General Partner
Life Sciences
FinTech
Crypto
Future Tech

Portfolio Highlights

Clark - digital insurance
Grover - device subscriptions
SellerX - e-commerce rollup

Team

Auto-detected from Elevat3 Capital's website.

Christian Angermayer
Co-Founder & General Partner

Serial entrepreneur and investor, founder of Elevat3 Capital and Apeiron Investment Group.

Life Sciences
FinTech
Crypto
Future Tech
Checked Aug 2026
Dr. Marlon Braumann
Co-Founder & General Partner

Co-founder and general partner focused on venture investments across Europe.

Life Sciences
FinTech
Crypto
Future Tech
Checked Aug 2026
Thomas Hanke
Co-Founder & General Partner

Co-founder and general partner at Elevat3 Capital.

Life Sciences
FinTech
Crypto
Future Tech
Checked Aug 2026

Focus and check size from the firm's website. Website reachable as of Aug 2026.

Ready to Reach Elevat3 Capital?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.